MedPath

APEX PHARMA MARKETING PTE. LTD.

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

174

HSA:174

Drug Approvals

MOXIFLOXACIN-AFT SOLUTION FOR INFUSION 400MG/250ML

Approval Date
May 7, 2025
HSA

ACTEIN GRANULES 100MG

Approval Date
Apr 29, 2025
HSA

PALAVO SUSPENSION 120MG/5ML

Approval Date
Apr 2, 2025
HSA

TERLIPRESSIN-AFT SOLUTION FOR INJECTION 0.85MG/8.5ML

Approval Date
Feb 28, 2025
HSA

Plerixafor-AFT solution for injection 24 mg/1.2 mL

Approval Date
Dec 12, 2024
HSA

LATA-T LATANOPROST & TIMOLOL EYE DROPS 0.005% & 0.5% w/v

Approval Date
Aug 27, 2024
HSA

MERO-AFT POWDER FOR INJECTION 500MG/VIAL

Approval Date
Aug 26, 2024
HSA

MERO-AFT POWDER FOR INJECTION 1000MG/VIAL

Approval Date
Aug 26, 2024
HSA

TYMORA THROAT SPRAY 0.3% W/V

Approval Date
Jul 24, 2024
HSA

ARISTO-LATA Latanoprost Eye Drops 0.005% w/v

Approval Date
Jun 11, 2024
HSA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 18
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.